123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.
Psychiatry Res Neuroimaging
; 261: 75-79, 2017 Mar 30.
Article
em En
| MEDLINE
| ID: mdl-28152401
ABSTRACT
123I-metaiodobenzylguanidine cardiac scintigraphy (MIBG) is a useful imaging technique for the diagnosis of dementia with Lewy bodies (DLB). However, MIBG has a serious disadvantage in that it demands a long examination time. The objective of this study was to evaluate statistically the usefulness of the heart/mediastinum ratio (H/M) from the early phase of MIBG for the differential diagnosis of DLB. In total, 113 patients were examined, including 32 non-DLB (19 with Alzheimer's dementia) and 79 DLB patients. The mean early-H/M ratio was 2.83 in the non-DLB group and 1.95 in the DLB group. The mean delayed-H/M ratio was 3.0 in the non-DLB group and 1.76 in the DLB group. With a cutoff point of 2.27 on early images, the sensitivity, specificity, and diagnostic accuracy were 65%, 94%, and 73%, respectively, and the area under the curve was 0.82, indicating moderate accuracy. This analysis indicates that images from the early phase of MIBG alone are sufficient for the differential diagnosis of Alzheimer's disease and DLB.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
3-Iodobenzilguanidina
/
Doença por Corpos de Lewy
/
Imagem de Perfusão do Miocárdio
/
Doença de Alzheimer
/
Coração
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article